InsiderSignal.AI

InsiderSignal.ai

BHVN - Biohaven Ltd.

Insider Purchase by Childs John W (Dir)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

3 months ago, Childs John W, serving as Dir at Biohaven Ltd. (BHVN), purchased 3,333,333 shares at $7.50 per share, for a total transaction value of $24,999,998.00. Following this transaction, Childs John W now holds 9,876,729 shares of BHVN.

This purchase represents a 51.00% increase in Childs John W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, November 13, 2025 and publicly disclosed via SEC Form 4 filing on Monday, November 17, 2025, 4 days after the trade was made.

Biohaven Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Childs John W

Dir

John W. Childs is an accomplished private equity executive serving as an Independent Director at Biohaven Ltd. (NYSE: BHVN) since September 2022.[[2]](https://www.biohaven.com/about/board-of-directors/)[[5]](https://app.boardroomalpha.com/profiles/people/A1002910-JOHN_W_CHILDS) He is the Chairman and Partner of J.W. Childs Associates, L.P., a private equity firm he co-founded in 1995, focusing on life sciences, real estate, and consumer brands.[[2]](https://www.biohaven.com/about/board-of-directors/)[[3]](https://coolidgefoundation.org/the-foundation-historic-site/foundation/john-w-childs/) Previously, he was Senior Managing Director at Thomas H. Lee Company (1991-1995), managing leveraged buyouts, and spent 17 years at Prudential Insurance Company in investment roles.[[2]](https://www.biohaven.com/about/board-of-directors/) Childs has a distinguished board career, including past Chairmanships at CHG Healthcare Services, Sunny Delight, and Kosta Browne, and current directorships at Realm, LLC (premium Napa wines), Pyramid Biosciences, OMAX Health, and Basin Holdings.[[2]](https://www.biohaven.com/about/board-of-directors/)[[3]](https://coolidgefoundation.org/the-foundation-historic-site/foundation/john-w-childs/) On November 13, 2025, he purchased 3,333,333 common shares of Biohaven for $25 million at $7.50 per share, increasing his holdings by 52%, signaling strong confidence in the company.[[1]](https://www.investing.com/news/insider-trading-news/biohaven-ltd-director-childs-buys-25m-in-common-shares-93CH-4362079)[[4]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/independent-director-of-biohaven-john-childs-buys-52-more-sh) He holds a B.A. from Yale University and an M.B.A. from Columbia University.[[2]](https://www.biohaven.com/about/board-of-directors/)[[3]](https://coolidgefoundation.org/the-foundation-historic-site/foundation/john-w-childs/)

View full insider profile →

Trade Price

$7.50

Quantity

3,333,333

Total Value

$24,999,998.00

Shares Owned

9,876,729

Trade Date

Thursday, November 13, 2025

101 days ago

SEC Filing Date

Monday, November 17, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Biohaven Ltd.

Company Overview

No company information available
View news mentioning BHVN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/1246021

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime